Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05391646

Pulmonary Embolism Registry

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Universidade do Porto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute Pulmonary Embolism (PE) is the most serious clinical presentation of venous thromboembolism (VTE), a leading cause of cardiovascular mortality, exceeded only by stroke and myocardial infarction. Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe chronic form of CTED and it occurs in 2-4% of patients after acute PE. In Portugal little is known about PE epidemiology and its outcomes, including complications like CTED. The main goal of this study is, therefore, to understand PE epidemiology and complications in the northern region of Portugal. This information can enable the organization of a structured health care network that can potentially benefit all PE patients.

Conditions

Timeline

Start date
2023-10-31
Primary completion
2023-12-16
Completion
2026-06-16
First posted
2022-05-26
Last updated
2023-10-19

Source: ClinicalTrials.gov record NCT05391646. Inclusion in this directory is not an endorsement.

Pulmonary Embolism Registry (NCT05391646) · Clinical Trials Directory